[go: up one dir, main page]

PL1954264T3 - Sposób wytwarzania epoksybutanolowych związków pośrednich - Google Patents

Sposób wytwarzania epoksybutanolowych związków pośrednich

Info

Publication number
PL1954264T3
PL1954264T3 PL06804890T PL06804890T PL1954264T3 PL 1954264 T3 PL1954264 T3 PL 1954264T3 PL 06804890 T PL06804890 T PL 06804890T PL 06804890 T PL06804890 T PL 06804890T PL 1954264 T3 PL1954264 T3 PL 1954264T3
Authority
PL
Poland
Prior art keywords
formula
epoxybutanol
intermediates
preparation
ethyl
Prior art date
Application number
PL06804890T
Other languages
English (en)
Inventor
Marc Muller
Lin Xu
Original Assignee
Basilea Pharmaceutica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharmaceutica Ag filed Critical Basilea Pharmaceutica Ag
Publication of PL1954264T3 publication Critical patent/PL1954264T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/08Compounds containing oxirane rings with hydrocarbon radicals, substituted by halogen atoms, nitro radicals or nitroso radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrane Compounds (AREA)
PL06804890T 2005-12-01 2006-11-29 Sposób wytwarzania epoksybutanolowych związków pośrednich PL1954264T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05026163 2005-12-01
PCT/CH2006/000671 WO2007062542A2 (en) 2005-12-01 2006-11-29 Process for the manufacture of epoxybutanol intermediates
EP06804890A EP1954264B1 (en) 2005-12-01 2006-11-29 Process for the manufacture of epoxybutanol intermediates

Publications (1)

Publication Number Publication Date
PL1954264T3 true PL1954264T3 (pl) 2010-02-26

Family

ID=36178579

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06804890T PL1954264T3 (pl) 2005-12-01 2006-11-29 Sposób wytwarzania epoksybutanolowych związków pośrednich

Country Status (19)

Country Link
US (2) US7816537B2 (pl)
EP (2) EP1954264B1 (pl)
JP (1) JP5329969B2 (pl)
KR (1) KR101191682B1 (pl)
CN (1) CN101321522B (pl)
AT (1) ATE444747T1 (pl)
AU (2) AU2006319657B2 (pl)
BR (1) BRPI0619120B1 (pl)
CA (2) CA2711852C (pl)
CY (1) CY1110588T1 (pl)
DE (1) DE602006009698D1 (pl)
DK (1) DK1954264T3 (pl)
ES (1) ES2333258T3 (pl)
HR (1) HRP20090675T1 (pl)
PL (1) PL1954264T3 (pl)
PT (1) PT1954264E (pl)
SI (1) SI1954264T1 (pl)
WO (1) WO2007062542A2 (pl)
ZA (1) ZA200804218B (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20130862T1 (hr) 2009-09-21 2013-10-25 Gilead Sciences, Inc. Procesi i intermedijeri za pripravu analoga 1'-cijanokarbanukleozida
SI2595980T1 (sl) 2010-07-22 2014-11-28 Gilead Sciences, Inc. Postopki in sestavki za zdravljenje paramyxoviridae virusnih infekcij
HRP20170171T1 (hr) 2012-08-07 2017-04-07 Basilea Pharmaceutica Ag Postupak za proizvodnju isavukonazola ili ravukonazola
WO2015150947A1 (en) 2014-03-29 2015-10-08 Wockhardt Limited A process for the preparation of isavuconazole and its intermediates
TWI740546B (zh) 2014-10-29 2021-09-21 美商基利科學股份有限公司 製備核糖苷的方法
LT3785717T (lt) 2015-09-16 2022-04-11 Gilead Sciences, Inc. Coronaviridae infekcijų gydymo būdai
CN105367528A (zh) * 2015-11-10 2016-03-02 南通诺泰生物医药技术有限公司 一种三唑类药物中间体(d)-1-(1-环烷仲胺基)-2-(2-四氢吡喃基)氧-1-丙酮类化合物及合成方法
CN110869028B (zh) 2017-03-14 2023-01-20 吉利德科学公司 治疗猫冠状病毒感染的方法
CA3178212A1 (en) 2017-05-01 2018-11-08 Gilead Sciences, Inc. Crystalline forms of (s)-2-ethylbutyl 2-(((s)-(((2r,3s,4r,5r)-5-(4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy) phosphoryl)amino)propanoate
EP3651734B1 (en) 2017-07-11 2024-11-13 Gilead Sciences, Inc. Compositions comprising an rna polymerase inhibitor and cyclodextrin for treating viral infections
SG11201911637QA (en) 2017-08-10 2020-01-30 Sumitomo Chemical Co Process for producing epoxy alcohol compound
AU2021214911A1 (en) 2020-01-27 2022-07-21 Gilead Sciences, Inc. Methods for treating SARS CoV-2 infections
CA3169340A1 (en) 2020-03-12 2021-09-16 Pavel R. Badalov Methods of preparing 1'-cyano nucleosides
WO2021207049A1 (en) 2020-04-06 2021-10-14 Gilead Sciences, Inc. Inhalation formulations of 1'-cyano substituted carbanucleoside analogs
CA3179226A1 (en) 2020-05-29 2021-12-02 Tomas Cihlar Remdesivir treatment methods
PE20230618A1 (es) 2020-06-24 2023-04-14 Gilead Sciences Inc Analogos de nucleosido de 1'-ciano y usos de los mismos
DK4204421T3 (da) 2020-08-27 2024-05-27 Gilead Sciences Inc Forbindelser og fremgangsmåder til behandling af virale infektioner
TWI867455B (zh) 2022-03-02 2024-12-21 美商基利科學股份有限公司 用於治療病毒感染的化合物及方法
CN115536643A (zh) * 2022-12-05 2022-12-30 南京桦冠生物技术有限公司 一种艾沙康唑类药物关键中间体的制备方法
US12357577B1 (en) 2024-02-02 2025-07-15 Gilead Sciences, Inc. Pharmaceutical formulations and uses thereof
CN119264078B (zh) * 2024-12-09 2025-08-01 浙江世佳科技股份有限公司 一种(5s,6r)-5,6-环氧-2-十七碳炔-1-醇的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3452213B2 (ja) * 1994-07-05 2003-09-29 エーザイ株式会社 抗真菌剤及びその製造方法
WO1999045008A1 (en) 1998-03-06 1999-09-10 F. Hoffmann-La Roche Ag 3-[4-(4-cyanophenyl)thiazol-2-y)]-1-(1h-1,2,4-triazol-1-yl)-butan-2-ol derivatives having antifungal activity
US6133485A (en) * 1998-04-15 2000-10-17 Synphar Laboratories, Inc. Asymmetric synthesis of 2-(2,4-difluorophenyl)-1-heterocycl-1-yl butan-2,3-diols
US6391903B1 (en) * 1999-09-09 2002-05-21 Sankyo Company, Limited Triazole derivatives having antifungal activity
US6884892B2 (en) 2002-06-20 2005-04-26 Sumitomo Chemical Company, Limited Production methods of epoxytriazole derivative and intermediate therefor
JP4627413B2 (ja) * 2003-05-06 2011-02-09 三井化学株式会社 1−アゾール−2−フェニル−2、3−プロパンジオール誘導体の製造法

Also Published As

Publication number Publication date
CA2629092A1 (en) 2007-06-07
BRPI0619120B1 (pt) 2023-10-10
KR101191682B1 (ko) 2012-10-16
AU2010203301A1 (en) 2010-08-12
BRPI0619120A2 (pt) 2011-09-13
US20090299073A1 (en) 2009-12-03
CA2711852A1 (en) 2007-06-07
US20110021794A1 (en) 2011-01-27
CA2711852C (en) 2011-10-04
KR20080075014A (ko) 2008-08-13
HRP20090675T1 (hr) 2010-01-31
WO2007062542A2 (en) 2007-06-07
EP1954264A2 (en) 2008-08-13
DK1954264T3 (da) 2010-01-11
JP5329969B2 (ja) 2013-10-30
CN101321522B (zh) 2012-05-30
ES2333258T3 (es) 2010-02-18
US7816537B2 (en) 2010-10-19
ATE444747T1 (de) 2009-10-15
AU2010203301B2 (en) 2012-06-21
WO2007062542A3 (en) 2007-11-01
CA2629092C (en) 2012-01-03
SI1954264T1 (sl) 2010-01-29
ZA200804218B (en) 2009-01-28
JP2009517413A (ja) 2009-04-30
EP2133345A1 (en) 2009-12-16
CN101321522A (zh) 2008-12-10
AU2006319657A1 (en) 2007-06-07
AU2006319657B2 (en) 2010-08-12
DE602006009698D1 (de) 2009-11-19
PT1954264E (pt) 2009-12-23
EP1954264B1 (en) 2009-10-07
CY1110588T1 (el) 2015-04-29
US8076494B2 (en) 2011-12-13

Similar Documents

Publication Publication Date Title
ZA200804218B (en) Process for the manufacture of epoxybutanol intermediates
TW200510381A (en) Novel 2-pyridinecarboxamide derivatives
ATE372767T1 (de) Dpp-iv-hemmer
ECSP099091A (es) Profarmaco de compuesto de cinamida
EA017861B9 (ru) Способ получения 4-оксохинолинового соединения
TW200624421A (en) Method for preparing n-phenylpyrazole-1-carboxamides
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
EP1795536A4 (en) PHOSPHORAMIDITE COMPOUND AND PROCESS FOR THE PREPARATION OF OLIGO RNA
SI1781683T1 (sl) Postopek za pripravo 17-vinil-triflatov kot intermediatov
IL208290A0 (en) Process for the preparation of 10-deacetyl-bis-7, 10- trichloroacetylbaccatin iii
EP1775289A4 (en) NEW IMIDAZOLIDINE DERIVATIVES
DK1961734T3 (da) Aminforbindelse og anvendelse deraf til medicinske formål
DE60233664D1 (de) Verfahren zur herstellung von pyridinverbindungen
NZ614088A (en) Process for preparing pyridinamines and novel polymorphs thereof
DE60006857D1 (de) Verfahren zur herstellung von pyridinmethanol-verbindungen
UA96149C2 (en) Method for producing 4-oxoquinoline compound
EA200801365A1 (ru) Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины
IL183805A0 (en) Process for preparing substituted thiophenesulfonyl isocyanates
DK1489080T3 (da) Fremgangsmåde til frembringelse af cilostazol
NO20053997D0 (no) Oligosaccharidderivat
SE0402734D0 (sv) Antimiicrobial compounds
TW200700370A (en) Producing method of haloalkylether compounds
ATE505456T1 (de) Verfahren zur herstellung eines 2-substituierten pyridinderivats
TH77089A (th) กระบวนการเคมี
ATE516278T1 (de) Verfahren zur herstellung von amidverbindungen